Delivery Order SPE2DB24D9213-SPE2DB25FCGLA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The products will be delivered to Park Ridge, Illinois and support the federal pharmaceutical supply chain...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a continuation of DLA's pharmaceutical supply operations through its broader procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order utilizes firm fixed-price pricing and represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $33,402.60 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,817.45, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of August 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
- The Defense Logistics Agency (DLA) awarded a $11,134.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 30, 2025, for the supply of YF-VAX 1 dose vials. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at $499.9 million through November 2026. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the YF-VAX 1 dose vaccine vials and has a completion date of November 30, 2021. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, valued at $2,226.84, was executed on August 12, 2025, with an ultimate completion date of September 3, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis leveraging its small business...
- SPE2DB24D9213Indefinite Delivery Contract
- SPE2DB24D9213-SPE2DB25FCGLADelivery Order
The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open market while leveraging its small business status. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. Under this IDC, the DLA issues firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering prescription medications, biologics, vaccines, and medical consumables distributed to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/21/25 |